D84. Pre-operative Lymphedema Risk Factors in Patients with Inflammatory Breast Cancer: Optimizing Patient Selection for LYMPHA

• Colby J. Hyland, BA,
• Libby R. Copeland-Halperin, MD,
• David Xiang, BA,
• Goutam Gadiraju, BA,
• Jennifer R. Bellon, MD,
• Filipa Lynce, MD,
• Tanujit Dey, PhD,
• Sean J. Ryan, MA, MS,
• Faina Nakhlis, MD,
• Justin M. Broyles, MD

Affiliations

Colby J. Hyland, BA

1 Harvard Medical School, Boston, MA, USA

Libby R. Copeland-Halperin, MD

2 Northwell Health, New York, NY, USA

David Xiang, BA

1 Harvard Medical School, Boston, MA, USA

Goutam Gadiraju, BA

1 Harvard Medical School, Boston, MA, USA

Jennifer R. Bellon, MD

3 Dana-Farber Cancer Institute, Boston, MA, USA

Filipa Lynce, MD

3 Dana-Farber Cancer Institute, Boston, MA, USA

Tanujit Dey, PhD

4 Harvard University, Boston, MA, USA

Sean J. Ryan, MA, MS

3 Dana-Farber Cancer Institute, Boston, MA, USA

Faina Nakhlis, MD

3 Dana-Farber Cancer Institute, Boston, MA, USA

Justin M. Broyles, MD

5 Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA.